Future Science Group
Browse
Supplement Figure 1(B).TIF (186.48 kB)

Supplement Figure 1(B) Impact of nab-paclitaxel plus PD-1/PD-L1 inhibitor on chemorefractory relapsed small-cell lung cancer

Download (186.48 kB)
figure
posted on 2023-05-12, 13:31 authored by Fengchun Mu, Bingjie Fan, Haoqian Li, Wenru Qin, Chunni Wang, Bing Zou, Linlin Wang

Supplement Figure 1(B) Impact of nab-paclitaxel plus PD-1/PD-L1 inhibitor on chemorefractory relapsed small-cell lung cancer 

Funding

This research was supported by National Natural Science Foundation of China (grant no. 82172865), Start-up fund of Shandong Cancer Hospital (grant no. 2020-B14), Clinical Research Special Fund of Wu Jieping Medical Foundation (grant nos. 320.6750.2021-02-51 and 320.6750.2021-17-13). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

History

Usage metrics

    Future Oncology

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC